刘明波,何新叶,杨晓红,王增武,胡盛寿

• 1:国家心血管病中心北京协和医学院中国医学科学院阜外医院

摘要(Abstract)：

由于我国居民不健康生活方式突出，人口老龄化及城镇化进程加速，心血管疾病（CVD）危险因素对居民健康的影响越加显著，我国CVD的发病率仍持续增高。推算CVD现患人数3.3亿，其中脑卒中1 300万，冠心病1 139万，心力衰竭890万，肺源性心脏病500万，心房颤动487万，风湿性心脏病250万，先天性心脏病200万，外周动脉疾病4 530万，高血压2.45亿。CVD给居民和社会带来的经济负担日渐加重，已成为重大的公共卫生问题。而CVD防治的拐点尚未到来，加强政府主导的CVD防治工作刻不容缓。

关键词(KeyWords)： 心血管疾病;流行病学;疾病负担;危险因素;患病率;死亡率;康复;基础研究;器械研发;费用

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 刘明波,何新叶,杨晓红,王增武,胡盛寿

参考文献(References)：

• [1]国家心血管病中心.中国心血管健康与疾病报告2023[M].北京:中国协和医科大学出版社,2024.
• [2]Wang H,Zhang H,Zou Z.Changing profiles of cardiovascular disease and risk factors in China:a secondary analysis for the Global Burden of Disease Study 2019[J].Chin Med J(Engl),2023,136(20):2431-2441.DOI:10.1097/CM9.0000000000002741.
• [3]李镒冲,刘世炜,曾新颖,等.1990~2016年中国及省级行政区心血管病疾病负担报告[J].中国循环杂志,2019,34(8):729-740.DOI:10.3969/j.issn.1000-3614.2019.08.001.
• [4]Liu S,Li Y,Zeng X,et al.Burden of cardiovascular diseases in China,1990-2016:findings from the 2016 Global Burden of Disease Study[J].JAMA Cardiol,2019,4(4):342-352.DOI:10.1001/j amacardio.2019.0295.
• [5]国家卫生健康委员会.中国卫生健康统计年鉴2022[M].北京:中国协和医科大学出版社,2022.
• [6]Ma Q,Li R,Wang L,et al.Temporal trend and attributable risk factors of stroke burden in China,1990-2019:an analy sis for the Global Burden of Disease Study 2019[J].Lancet Public Health,2021,6(12):e897-e906.DOI:10.1016/S2468-2667(21)00228-0.
• [7]Sun T,Chen S,Wu K,et al.Trends in incidence and mortality of stroke in China from 1990 to 2019[J].Front Neurol,2021,12:759221.DOI:10.338 9/fneur.2021.759221.
• [8]Wu H.Xu L,Zhao X,et al.Indobufen or aspirin on top of clopidogrel after coronary drug-eluting stent implantation(OPTION):a randomized,open-label,end point-blinded,noninferiority trial[J].Circulation,2023,147(3):212-222.DOI:10.1161/CIRCULATIONAHA.122.062762.
• [9]Ding T,Yuan X,Chen K,et al.Simultaneous hybrid coronary revascularization vs.conventional strategies for multivessel coronary artery disease:a 10-year follow-up[J].JACC Cardiovasc Interv,2023,16(1):50-60.DOI:10.1016/j.jcin.2022.09.049.
• [10]Wang Y,Zhu H,Hou X,et al.Randomized trial of left bundle branch vs biventricular pacing for cardiac resynchronization therapy[J].J Am Coll Cardiol,2022,80(13):1205-1216.DOI:10.1016/j.jacc.2022.07.019.
• [11]Ge Z,Pan W,Li W,et al.Impact of leaflet tethering on residual regurgitation in patients with degenerative mitral disease after interventional edge-to-edge repair[J].Front Cardiovasc Med,2021,8:647701.DOI:10.3389/fcvm.2021.647701.
• [12]国家心血管病中心,国家结构性心脏病介入质控中心,中华医学会心血管病学分会,等.经导管主动脉瓣置换术临床实践指南[J].中华医学杂志,2023,103(12):886-900.DOI:10.3760/cma.j.cn112137-20221106-023 32.
• [13]张海波,侯晓彤,郭应强.心尖途径经导管主动脉瓣置换术围术期管理规范专家建议[J].中国胸心血管外科临床杂志,2023,30(7):927-935.DOI:10.7507/1007-4848.202304023.
• [14]卢志南,宋光远,潘文志,等.中国经导管二尖瓣缘对缘修复术临床路径(2022版)精简版[J].中国介入心脏病学杂志,2023,31(3):161-173.DOI:10.3969/j.issn.1004-8812.2023.03.001.
• [15]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.经导管主动脉瓣植入术后抗血栓治疗中国专家共识[J].中华心血管病杂志,2022,50(2):117-131.DOI:10.3760/cma.j.cn112148-20210721-00608.
• [16]中华医学会心血管病学分会.经导管二尖瓣缘对缘修复术的中国专家共识[J].中华心血管病杂志,2022,50(9):853-863.DOI:10.3760/cma.j.cn112148-20211212-01067.
• [17]中国医师协会心血管内科医师分会,中国康复医学会心脏介入治疗和康复专业委员会,中国医院协会心脏康复管理专业委员会.经导管二尖瓣缘对缘修复术患者心脏康复中国专家共识[J].中国介入心脏病学杂志,2023,31(4):252-265.DOI:10.3969/j.issn.1004-8812.2023.04.002.
• [18]Zhao R,Qiu J,Dai L,et al.Current surgical management of acute type A aortic dissection in China:a multicenter registry study[J].JACC Asia,2022,2(7):869-878.DOI:10.1016/j.jacasi.2022.08.009.
• [19]Zhang H,Wei Y,Zhang C,et al.Pulmonary artery denervation for pulmonary arterial hypertension:a sham-controlled randomized PADN-CFDA trial[J].JACC Cardiovasc Interv,2022,15(23):2412-2423.DOI:10.1016/j.jcin.2022.09.013.
• [20]Zhou YP,Wei YP,Yang YJ,et al.Percutaneous pulmonary angioplasty for patients with Takayasu arteritis and pulmonary hypertension[J].J Am Coll Cardiol,2022,79(15):1477-1488.DOI:10.1016/j.jacc.2022.01.052.
• [21]Fang J,Liu Y,Zhu Y,et al.First-in-human transapical beating-heart septal myectomy in patients with hypertrophic obstructive cardiomyopathy[J].J Am Coll Cardiol,2023,82(7):575-586.DOI:10.1016/j.jacc.2023.05.052.
• [22]Gao P,Wang T,Wang D,et al.Effect of stenting plus medical therapy vs.medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis:the CASSISS randomized clinical trial[J].JAMA,2022,328(6):534-542.DOI:10.1001/jama.2022.12000.
• [23]Huo X,Ma G,Tong X,et al.Trial of endovascular therapy for acute ischemic stroke with large infarct[J].New Engl J Med,2023,388(14):1272-1283.DOI:10.1056/NEJMoa2213379.